Jazz Pharmaceuticals JAZZ Investment Purchases
Investment Purchases at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireInvestments.
The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's investment purchases.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's investment purchases?
- Jazz Pharmaceuticals (JAZZ) reported investment purchases of $500M in Q1 2026.
- How has Jazz Pharmaceuticals's investment purchases changed year-over-year?
- Jazz Pharmaceuticals's investment purchases increased by 13.6% year-over-year, from $440.1M to $500M.
- What is the long-term trend for Jazz Pharmaceuticals's investment purchases?
- Over 4 years (2021 to 2025), Jazz Pharmaceuticals's investment purchases has grown at a 187.4% compound annual growth rate (CAGR), from $26.82M to $1.83B.
- What does investment purchases mean?
- The amount of cash spent on buying financial investments or securities.
- How do you interpret investment purchases?
- High purchases indicate active treasury management or capital deployment into liquid assets.
- How does investment purchases compare across companies?
- Common for companies with large cash balances; peers with high cash reserves often show significant activity here.